GENEVA, July 2 -- HANGZHOU SHOUYAN BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. filed a patent application (CN2025/144156) for “TRISUBSTITUTED TETRAHYDROISOQUINOLINE AMIDE DERIVATIVE AND PHARMACEUTICAL USE THEREOF”. With publication no. WO/2026/130567, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07D 405/06
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....